Group One Trading, L.P. Liquidia Corp Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Liquidia Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 20,584 shares of LQDA stock, worth $485,988. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,584
Previous 35,079
41.32%
Holding current value
$485,988
Previous $517,000
50.48%
% of portfolio
0.01%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding LQDA
# of Institutions
210Shares Held
47.5MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$100 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$100 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$84.8 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$70.8 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$58.4 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.52B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...